Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

1.

Frequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational study.

Dueñas H, Lee A, Brnabic AJ, Chung KF, Lai CH, Badr MG, Uy-Ponio T, Ruiz JR, Varrey P, Jian H, Dossenbach M.

Int J Psychiatry Clin Pract. 2011 Jun;15(2):80-90. doi: 10.3109/13651501.2011.572169. Epub 2011 Apr 26.

PMID:
22121855
[PubMed - indexed for MEDLINE]
2.

Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.

Dueñas H, Brnabic AJ, Lee A, Montejo AL, Prakash S, Casimiro-Querubin ML, Khaled M, Dossenbach M, Raskin J.

Int J Psychiatry Clin Pract. 2011 Nov;15(4):242-54. doi: 10.3109/13651501.2011.590209.

PMID:
22121997
[PubMed - indexed for MEDLINE]
3.

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder.

Clayton A, Kornstein S, Prakash A, Mallinckrodt C, Wohlreich M.

J Sex Med. 2007 Jul;4(4 Pt 1):917-29.

PMID:
17627739
[PubMed - indexed for MEDLINE]
4.

Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder.

Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ.

J Clin Psychiatry. 2005 Jun;66(6):686-92.

PMID:
15960560
[PubMed - indexed for MEDLINE]
5.

A pragmatic 12-week, randomized trial of duloxetine versus generic selective serotonin-reuptake inhibitors in the treatment of adult outpatients in a moderate-to-severe depressive episode.

Martinez JM, Katon W, Greist JH, Kroenke K, Thase ME, Meyers AL, Edwards SE, Marangell LB, Shoemaker S, Swindle R.

Int Clin Psychopharmacol. 2012 Jan;27(1):17-26. doi: 10.1097/YIC.0b013e32834ce11b.

PMID:
22027844
[PubMed - indexed for MEDLINE]
6.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
[PubMed - indexed for MEDLINE]
7.

Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.

Wade AG, Fernández JL, François C, Hansen K, Danchenko N, Despiegel N.

Pharmacoeconomics. 2008;26(11):969-81.

PMID:
18850765
[PubMed - indexed for MEDLINE]
8.

Duloxetine in the treatment of major depressive disorder: an open-label study.

Hudson JI, Perahia DG, Gilaberte I, Wang F, Watkin JG, Detke MJ.

BMC Psychiatry. 2007 Aug 28;7:43.

PMID:
17725843
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Duloxetine in the treatment of major depressive disorder: a double-blind clinical trial.

Goldstein DJ, Mallinckrodt C, Lu Y, Demitrack MA.

J Clin Psychiatry. 2002 Mar;63(3):225-31.

PMID:
11926722
[PubMed - indexed for MEDLINE]
10.

Duloxetine for the treatment of major depressive disorder: a closer look at efficacy and safety data across the approved dose range.

Mallinckrodt CH, Prakash A, Andorn AC, Watkin JG, Wohlreich MM.

J Psychiatr Res. 2006 Jun;40(4):337-48. Epub 2005 Nov 4.

PMID:
16271726
[PubMed - indexed for MEDLINE]
11.

Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ.

Eur Psychiatry. 2006 Sep;21(6):367-78. Epub 2006 May 11.

PMID:
16697153
[PubMed - indexed for MEDLINE]
12.

Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram).

Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M.

Neuropsychobiology. 2007;56(2-3):73-85. Epub 2007 Nov 23.

PMID:
18037817
[PubMed - indexed for MEDLINE]
13.

The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study.

Safarinejad MR.

BJU Int. 2010 Sep;106(6):840-7. doi: 10.1111/j.1464-410X.2009.09154.x. Epub 2010 Jan 8.

PMID:
20067456
[PubMed - indexed for MEDLINE]
14.

Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.

Brannan SK, Mallinckrodt CH, Brown EB, Wohlreich MM, Watkin JG, Schatzberg AF.

J Psychiatr Res. 2005 Jan;39(1):43-53.

PMID:
15504423
[PubMed - indexed for MEDLINE]
15.

A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.

Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ.

Arthritis Rheum. 2004 Sep;50(9):2974-84.

PMID:
15457467
[PubMed - indexed for MEDLINE]
Free Article
16.

Duloxetine efficacy for major depressive disorder in male vs. female patients: data from 7 randomized, double-blind, placebo-controlled trials.

Kornstein SG, Wohlreich MM, Mallinckrodt CH, Watkin JG, Stewart DE.

J Clin Psychiatry. 2006 May;67(5):761-70.

PMID:
16841626
[PubMed - indexed for MEDLINE]
17.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trial.

Brecht S, Courtecuisse C, Debieuvre C, Croenlein J, Desaiah D, Raskin J, Petit C, Demyttenaere K.

J Clin Psychiatry. 2007 Nov;68(11):1707-16.

PMID:
18052564
[PubMed - indexed for MEDLINE]
19.

Duloxetine in major depressed patients resistant to SSRIs and/or venlafaxine.

Pitchot W, Scantamburlo G, Ansseau M.

Psychiatr Danub. 2010 Nov;22 Suppl 1:S106-7.

PMID:
21057413
[PubMed - indexed for MEDLINE]
20.

A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms.

Gaynor PJ, Gopal M, Zheng W, Martinez JM, Robinson MJ, Marangell LB.

Curr Med Res Opin. 2011 Oct;27(10):1849-58. doi: 10.1185/03007995.2011.609539. Epub 2011 Aug 12.

PMID:
21838411
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk